Transgenic Monocyte Chemoattractant Protein-1 (MCP-1) in Pancreatic Islets Produces Monocyte-Rich Insulitis Without Diabetes: Abrogation by a Second Transgene Expressing Systemic MCP-1

Journal of Immunology

Volumn 159, Issue 1, 1997, Pages 401-408

  Grewal, Iqbal S ^b   Rutledge, Barbara J ^a   Fiorillo, Joseph A ^a   Gu, Long ^a   Gladue, Ronald P ^c   Flavell, Richard A ^b   Rolling, Barrett J ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL MOTION; GENE TRANSFER; GENETICS; IMMUNOLOGY; METABOLISM; MONOCYTE; MOUSE; PANCREAS DISEASE; PANCREAS ISLET; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; CELL MOVEMENT; CHEMOKINE CCL2; GENE TRANSFER TECHNIQUES; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; MONOCYTES; PANCREATIC DISEASES;

EID: 0031178464     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Rollins, B. J. 1996. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol. Med. Today 2:198.
2. Oppenheim, J. J., C. O. C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" family. Annu. Rev. Immunol. 9:617.
3. Kelner, G. S., J. Kennedy, K. B. Bacon, S. Kleyensteuber, D. A. Largaespada, N. A. Jenkins, N. G. Copeland, J. F. Bazan, K. W. Moore, T. J. Schall, and A. Zlotnik. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395.
4. 3C motif. Nature 385:640.
5. Cochran, B. H., A. C. Reffel, and C. D. Stiles. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33:939.
6. Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties, Proc. Natl Acad. Sci. USA 85:3738.
7. Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169:1485.
8. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, and E. J. Leonard. 1989. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes. J. Immunol. 142:1956.
9. Alam, R., M. A. Lett-Brown, P. A. Forsythe, D. J. Anderson-Walters, C. Kenamore, C. Kormos, and J. A. Grant. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils. J. Clin. Invest. 89:723.
10. Kuna, P., S. R. Reddigari, D. Rucinski, J. J. Oppenheim, and A. P. Kaplan. 1992. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils, J. Exp. Med. 175:489.
11. Carr, M. W., S. J. Roth, E. Luther, S. S. Rose, and T. A. Springer. 1994. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc. Natl. Acad. Sci. USA 91:3652.
12. Barker, J. N. W. N., M. L. Jones, C. L. Swenson, V. Sarma, R. S. Mitra, P. A. Ward, K. J. Johnson, J. C. Fantone, V. M. Dixit, and B. J. Nickoloff. 1991. Monocyte chemotaxis and activating factor production by keratinocytes in response to IFN-γ. J. Immunol. 146:1192.
13. Koch, A. E., S. L. Kunkel, L. A. Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, M. D. Burdick, R. M. Pope, and R. M. Stricter. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90:772.
14. Nelken, N. A., S. R. Coughlin, D. Gordon, and J. N. Wilcox. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1121.
15. Yla-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, T. Sarkioja, T. Yoshimura, E. J. Leonard, J. L. Witztum, and D. Steinberg. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88:5252.
16. Jones, M. L., M. S. Mulligan, C. M. Flory, P. A. Ward, and J. S. Warren. 1992. Potential role of monocyte chemoattractant protein 1/JE in monocyte/macrophage-dependent IgA immune complex alveolitis in the rat. J. Immunol. 149:2147.
17. Flory, C. M., M. L. Jones, and J. S. Warren. 1993. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1. Lab. Invest. 69:396.
18. Zachariae, C. O. C., A. O. Anderson, H. L. Thompson, E. Appella, A. Mantovani, J. J. Oppenheim, and K. Matsushima. 1990. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 171:2177.
19. Ernst, C. A., Y. J. Zhang, P. R. Hancock, B. J. Rutledge, C. L. Corless, and B. J. Rollins. 1994. Biochemical and biological characterization of m urine MCP-1: identification of two functional domains. J. Immunol. 152:3541.
20. Rollins, B. J., and M. E. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mot. Cell. Biol. 11:3125.
21. Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148:1280.
22. Rutledge, B. J., H. Rayburn, R. Rosenberg, R. J. North, R. P. Gladue, C. L. Corless, and B. J. Rollins. 1995. High level monocyte chemonattractant protein-1 expression in transgenic mice increases their susceptibility to intracellulur pathogens. J. Immunol. 155:4838.
23. Fuentes, M. E., S. Durham K., M. R. Swerdel, A. C. Lewin, D. S. Burton, J. R. Megill, R. Bravo, and S. A. Lira. 1995. Controlled recruitment of monocytes/macrophages to specific organs through transgenic expression of MCP-1, J. Immunol. 155:5769.
24. Sarvetnick, N., J. Shizuru, D. Liggitt, L. Martin, B. MeIntyre, A. Gregory, T. Parslow, and T. Stewart. 1990. Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-γ. Nature 346:844.
25. DiCosmo, B. F., D. Picarella, and R. A. Flavell. 1994. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice. Int. Immunol. 6:1829.
26. Picarella, D. E., A. Kratz, C. B. Li, N. H. Ruddle, and R. A. Flavell. 1993. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-α and TNF-β transgenic mice. J. Immunol. 150:4136.
27. Picarella, D. E., A. Kratz, C. B. Li, N. H. Ruddle, and R. A. Flavell. 1992. Insulitis in transgenic mice expressing tumor necrosis factor beta (lymphotoxin) in the pancreas. Proc. Natl. Acad. Sci. USA 89:10036.
28. Lee, M. S., R. Mueller, L. S. Wicker, L. B. Peterson, and N. Sarvetnick. 1996. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity. J. Exp. Med. 183:2663.
29. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Laird, P. W., A. Zijderveld, K. Linders, M. A. Rudnicki, R. Jaenisch, and A. Berns. 1991. Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19:4293.
31. Luo, Y., J. Laning, M. Hayashi, P. R. Hancock, B. Rollins, and M. E. Dorf. 1994. Serologic analysis of the mouse β chemokine JE/monocyte chemoattractant protein-1. J. Immunol 153:3708.
32. Falk, W., R. H. J. Goodwin, and E. J. Leonard. 1980. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods 33:239.
33. Yoshimura, T., and E. J. Leonard. 1990. Secretion by human fibroblasts of monocyte chemoattractant protein-1 (MCP-1), the product of gene JE. J. Immunol. 144:2377.
34. Rollins, B. J., P. Stier, T. E. Ernst, and G. G. Wong. 1989. The human homologue of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol 9:4687.
35. Leonard, E. J., and A. Skeel. 1985. Disposable microliter immunoabsorbent columns: construction and operation. J. Immunol. Methods 82:341.
36. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.
37. Nakamura, K., I. R. Williams, and T. S. Kupper. 1995. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J. Invest. Dermatol. 105:635.
38. Hechtman, D. H., M. I. Cybulsky, H. J. Fuchs, J. B. Baker, and M. A. Gimbrone. 1991. Intravascular IL-8: inhibitor of polymorphonuclcar leukocyte accumulation at sites of acute inflammation. J. Immunol. 147:883.
39. Bossink, A. W., L. Paemen, P. M. Jansen, C. E. Hack, L. G. Thijs, and J. Van Damme. 1995. Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood 86:3841.
40. Sylvester, I., A. F. Suffredini, A. J. Boujoukos, G. D. Martich, R. L. Danner, T. Yoshimura, and E. J. Leonard. 1993. Neutrophil attractant protein-1 and monocyte chemoattractant protein-1 in human serum: effects of intravenous lipopolysaccharide on free attractants. specific IgG autoantibodies and immune complexes. J. Immunol. 151:3292.
41. Noris, M., S. Bernasconi, F. Casiraghi, S. Sozzani, E. Gotti, G. Remuzzi, and A. Mantovani. 1995. Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab. Invest. 73:804.
42. Rovin, B. H., N. Doe, and L. C. Tan. 1996. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am. J. Kidney Dis. 27:640.
43. Wada, T., H. Yokoyama, S. B. Su, N. Mukaida, M. Iwano, K. Dohi, Y. Takahashi, T. Sasaki, K. Furuichi, C. Segawa, Y. Hisada, S. Ohta, K. Takasawa, K. Kobayashi, and K. Matsushima. 1996. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 49:761.
44. Higuchi, Y., P. Herrera, P. Muniesa, J. Huarte, D. Belin, P. Ohashi, P. Aichele, L. Orci, J. D. Vassalli, and P. Vassalli. 1992. Expression of a tumor necrosis factor-α transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176:1719.
45. Guerder, S., D. E. Picarella, P. S. Linsley, and R. A. Flavell. 1994. Costimulator B7-1 confers antigen-presenting-cell functions to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. USA 91:5138.
46. Grewal, I. S., K. D. Grewal, F. S. Wong, D. E. Picarella, C. A. J. Janeway, and R. A. Flavell. 1996. Local expression of transgene encoded TNFα in islets prevents autoimmune diabetes in NOD mice by preventing the development of auto-reactive islet specific T cells. J. Exp. Med. 184:1963.
47. Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78:1112.